Merck Defies Trade Headwinds: Q1 Profits Surge Past Estimates Despite $200M Tariff Toll

Merck has begun 2025 with a strong financial performance despite kicking off the year with higher-than-predicted profits while global trade tensions inflict a $200 million hit on its bottom line. The pharma giant's Q1 performance highlights strong growth in prime divisions, but also underscores the increasing cost of tariffs and changing global demand.

 

Major Highlights

Sources: Merck, Reuters, CNBC